NCT06797336
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06797336
Title A Study of PT0253 in Participants With KRAS G12D Mutated Advanced Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors PAQ Therapeutics, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
START Los Angeles RECRUITING Los Angeles California 90025 United States Details
Dana Farber/Massachusetts General Hospital, Inc RECRUITING Boston Massachusetts 02215 United States Details
START Midwest RECRUITING Grand Rapids Michigan 49546 United States Details
SCRI Lake Mary WITHDRAWN Nashville Tennessee 37203 United States Details
SCRI Oncology Partners WITHDRAWN Nashville Tennessee 37203 United States Details
New Experimental Therapeutics of San Antonio LLC RECRUITING San Antonio Texas 78229 United States Details
START - South Texas Accelerated Research Therapeutics, LLC RECRUITING San Antonio Texas 78229 United States Details
START Mountain Region RECRUITING West Valley City Utah 84119 United States Details
NEXT Virginia RECRUITING Fairfax Virginia 22031 United States Details
CHA University Bundang Medical Center RECRUITING Seongnam South Korea Details
Asan Medical Center RECRUITING Seoul South Korea Details
Samsung Medical Center RECRUITING Seoul South Korea Details
Seoul National University Bundang Hospital RECRUITING Seoul South Korea Details
Seoul National University Hospital RECRUITING Seoul South Korea Details
Severance Hospital, Yonsei University Health System RECRUITING Seoul South Korea Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field